Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy

被引:10
作者
Day, Ryan W. [1 ]
Badgwell, Brian D. [1 ]
Fournier, Keith F. [1 ]
Mansfield, Paul F. [1 ]
Aloia, Thomas A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
关键词
NSQIP; Gastroesophageal junction; GEJ; National Surgical Quality Improvement Program; GASTROESOPHAGEAL JUNCTION; HOSPITAL VOLUME; CANCER; ESOPHAGUS; ESOPHAGECTOMY; ADENOCARCINOMA; GASTRECTOMY; CARCINOMA; MORBIDITY; MORTALITY;
D O I
10.1007/s11605-015-2949-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastric cardia cancer is currently treated with several operations. The purpose of the current study was to compare outcomes associated with three common operative approaches. The ACS-NSQIP Participant Use File was searched to identify all patients with gastric cardia malignancy who underwent total gastrectomy (TG), transhiatal esophagectomy (THE), or thoraco-abdominal esophagectomy (TAE) between 2005 and 2012. Demographic, perioperative risk factors, and outcomes were analyzed. Overall, there were 982 patients identified in the database who met inclusion criteria. The median age was 65 years (range 20-88) and 807 (82.2 %) were male. The number of patients allocated to each approach was 204 TGs (20.8 %), 271 THE (27.6 %), and 507 TAE (51.6 %). All approaches had similar major morbidity, cardiopulmonary morbidity, and 30-day mortality, however, TAE was associated with the highest overall morbidity (TAE 49.9 % vs. TG 40.7 % and THE 43.5 %, p = 0.048). The independent risk factors predicting mortality were age greater than 65 years, history of myocardial infarction, and postoperative cardiopulmonary morbidity. For patients with proximal gastric cancer, the three most common operative approaches were associated with clinically-significant rates of overall and major morbidity. Approach-associated morbidity should be considered along with tumor location and extent when choosing a technique for resection of gastric cardia malignancy.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 25 条
[1]  
Acs, 2012, US GUID 2012 ACS NSQ
[2]   Time to adjuvant therapy and other variables in localized gastric and gastroesophageal junction (GEJ) cancer (IJGC-D-13-00162) [J].
Ahmed S. ;
Iqbal N. ;
Yadav S. ;
Zaidi A. ;
Ahmed O. ;
Alvi R. ;
Gardner D. ;
Haider K. .
Journal of Gastrointestinal Cancer, 2014, 45 (3) :284-290
[3]   Return to Intended Oncologic Treatment (RIOT): A Novel Metric for Evaluating the Quality of Oncosurgical Therapy for Malignancy [J].
Aloia, Thomas A. ;
Zimmitti, Giuseppe ;
Conrad, Claudius ;
Gottumukalla, Vijaya ;
Kopetz, Scott ;
Vauthey, Jean-Nicolas .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (02) :107-114
[4]   Hospital volume and survival in oesophagectomy and gastrectomy for cancer [J].
Anderson, Oliver ;
Ni, Zhifang ;
Moller, Henrik ;
Coupland, Victoria H. ;
Davies, Elizabeth A. ;
Allum, William H. ;
Hanna, George B. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (16) :2408-2414
[5]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[6]   Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J].
Biere, Surya S. A. Y. ;
Henegouwen, Mark I. van Berge ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Rosman, Camiel ;
Roig Garcia, Josep ;
Gisbertz, Suzanne S. ;
Klinkenbijl, Jean H. G. ;
Hollmann, Markus W. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
van der Peet, Donald L. ;
Cuesta, Miguel A. .
LANCET, 2012, 379 (9829) :1887-1892
[7]   RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
BLOT, WJ ;
DEVESA, SS ;
KNELLER, RW ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10) :1287-1289
[8]   Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008 [J].
Coupland, Victoria H. ;
Lagergren, Jesper ;
Luechtenborg, Margreet ;
Jack, Ruth H. ;
Allum, William ;
Holmberg, Lars ;
Hanna, George B. ;
Pearce, Neil ;
Moller, Henrik .
GUT, 2013, 62 (07) :961-966
[9]  
Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO
[10]  
2-U